Literature DB >> 32727273

Isoflurane inhibits a Kir4.1/5.1-like conductance in neonatal rat brainstem astrocytes and recombinant Kir4.1/5.1 channels in a heterologous expression system.

Mengchan Ou1,2, Fu-Shan Kuo2, Xinnian Chen2, Uri Kahanovitch3, Michelle L Olsen3, Guizhi Du1, Daniel K Mulkey2.   

Abstract

All inhalation anesthetics used clinically including isoflurane can suppress breathing; since this unwanted side effect can persist during the postoperative period and complicate patient recovery, there is a need to better understand how isoflurane affects cellular and molecular elements of respiratory control. Considering that astrocytes in a brainstem region known as the retrotrapezoid nucleus (RTN) contribute to the regulation of breathing in response to changes in CO2/H+ (i.e., function as respiratory chemoreceptors), and astrocytes in other brain regions are highly sensitive to isoflurane, we wanted to determine whether and how RTN astrocytes respond to isoflurane. We found that RTN astrocytes in slices from neonatal rat pups (7-12 days postnatal) respond to clinically relevant levels of isoflurane by inhibition of a CO2/H+-sensitive Kir4.1/5.1-like conductance [50% effective concentration (EC50) = 0.8 mM or ~1.7%]. We went on to confirm that similar levels of isoflurane (EC50 = 0.53 mM or 1.1%) inhibit recombinant Kir4.1/5.1 channels but not homomeric Kir4.1 channels expressed in HEK293 cells. We also found that exposure to CO2/H+ occluded subsequent effects of isoflurane on both native and recombinant Kir4.1/5.1 currents. These results identify Kir4.1/5.1 channels in astrocytes as novel targets of isoflurane. These results suggest astrocyte Kir4.1/5.1 channels contribute to certain aspects of general anesthesia including altered respiratory control.NEW & NOTEWORTHY An unwanted side effect of isoflurane anesthesia is suppression of breathing. Despite this clinical significance, effects of isoflurane on cellular and molecular elements of respiratory control are not well understood. Here, we show that isoflurane inhibits heteromeric Kir4.1/5.1 channels in a mammalian expression system and a Kir4.1/5.1-like conductance in astrocytes in a brainstem respiratory center. These results identify astrocyte Kir4.1/5.1 channels as novel targets of isoflurane and potential substrates for altered respiratory control during isoflurane anesthesia.

Entities:  

Keywords:  anesthesia; chemoreception; retrotrapezoid nucleus

Mesh:

Substances:

Year:  2020        PMID: 32727273      PMCID: PMC7509298          DOI: 10.1152/jn.00358.2020

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  48 in total

1.  The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics.

Authors:  J E Sirois; Q Lei; E M Talley; C Lynch; D A Bayliss
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

2.  Astrocytes in the retrotrapezoid nucleus sense H+ by inhibition of a Kir4.1-Kir5.1-like current and may contribute to chemoreception by a purinergic mechanism.

Authors:  Ian C Wenker; Orsolya Kréneisz; Akiko Nishiyama; Daniel K Mulkey
Journal:  J Neurophysiol       Date:  2010-10-06       Impact factor: 2.714

Review 3.  Selective actions of volatile general anaesthetics at molecular and cellular levels.

Authors:  N P Franks; W R Lieb
Journal:  Br J Anaesth       Date:  1993-07       Impact factor: 9.166

Review 4.  Diversity of astrocyte functions and phenotypes in neural circuits.

Authors:  Baljit S Khakh; Michael V Sofroniew
Journal:  Nat Neurosci       Date:  2015-07       Impact factor: 24.884

Review 5.  The role of glial-specific Kir4.1 in normal and pathological states of the CNS.

Authors:  Sinifunanya E Nwaobi; Vishnu A Cuddapah; Kelsey C Patterson; Anita C Randolph; Michelle L Olsen
Journal:  Acta Neuropathol       Date:  2016-03-09       Impact factor: 17.088

6.  Chemical regulation of ventilation during isoflurane sedation and anaesthesia in humans.

Authors:  R L Knill; H T Kieraszewicz; B G Dodgson; J L Clement
Journal:  Can Anaesth Soc J       Date:  1983-11

7.  Modulation of the heteromeric Kir4.1-Kir5.1 channel by multiple neurotransmitters via Galphaq-coupled receptors.

Authors:  Asheebo Rojas; Junda Su; Liang Yang; Ming Lee; Ningren Cui; Xiaoli Zhang; Dyanna Fountain; Chun Jiang
Journal:  J Cell Physiol       Date:  2008-01       Impact factor: 6.384

8.  General anesthesia selectively disrupts astrocyte calcium signaling in the awake mouse cortex.

Authors:  Alexander Stanley Thrane; Vinita Rangroo Thrane; Douglas Zeppenfeld; Nanhong Lou; Qiwu Xu; Erlend Arnulf Nagelhus; Maiken Nedergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

9.  Astrocytes control breathing through pH-dependent release of ATP.

Authors:  Alexander V Gourine; Vitaliy Kasymov; Nephtali Marina; Feige Tang; Melina F Figueiredo; Samantha Lane; Anja G Teschemacher; K Michael Spyer; Karl Deisseroth; Sergey Kasparov
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

10.  Biophysical and molecular mechanisms underlying the modulation of heteromeric Kir4.1-Kir5.1 channels by CO2 and pH.

Authors:  Z Yang; H Xu; N Cui; Z Qu; S Chanchevalap; W Shen; C Jiang
Journal:  J Gen Physiol       Date:  2000-07-01       Impact factor: 4.086

View more
  3 in total

Review 1.  Kir5.1 channels: potential role in epilepsy and seizure disorders.

Authors:  Alexander Staruschenko; Matthew R Hodges; Oleg Palygin
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-18       Impact factor: 5.282

Review 2.  Putative Roles of Astrocytes in General Anesthesia.

Authors:  Daniel K Mulkey; Michelle L Olsen; Mengchan Ou; Colin M Cleary; Guizhi Du
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

3.  Connexin 43 gap junction-mediated astrocytic network reconstruction attenuates isoflurane-induced cognitive dysfunction in mice.

Authors:  Rui Dong; Yuqiang Han; Linhao Jiang; Shuai Liu; Fujun Zhang; Liangyu Peng; Zimo Wang; Zhengliang Ma; Tianjiao Xia; Xiaoping Gu
Journal:  J Neuroinflammation       Date:  2022-03-07       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.